As of Oct 27
| -0.24 / -6.33%|
The 1 analysts offering 12-month price forecasts for Biostar Pharmaceuticals Inc have a median target of 147.00, with a high estimate of 147.00 and a low estimate of 147.00. The median estimate represents a +4,040.85% increase from the last price of 3.55.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.